No, according to a recent study of over 500 first cycle recipients of donor oocytes. Obese recipients do not have significantly lower rates of implantation or pregnancy or significantly higher rates of spontaneous abortions than women who are underweight, overweight (but not obese), or of normal weight.
No, according to a recent study of over 500 first cycle recipients of donor oocytes. Obese recipients do not have significantly lower rates of implantation or pregnancy or significantly higher rates of spontaneous abortions than women who are underweight, overweight (but not obese), or of normal weight.
Previous studies have found connections between maternal obesity and reduced fertility, lower live birth rates after IVF and intracytoplasmic sperm injections, and lower rates of pregnancy and implantation after ART. Other studies have linked obesity to insufficient follicle development, a lower oocyte count, and an increased requirement for gonadotropins.
But the authors of the current study claim that most of those reports looked at obesity's effect on ovarian function, not on endometrial receptivity. They say the current study excludes obesity's effects on ovarian follicular maturation and focuses instead on its effects on the endometrium, which appear to be nil.
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More